Skip to main content
OpenTrials

Clinical trial condition

Retroviridae Infections

Explore clinical trials studying Retroviridae Infections. Study availability and eligibility vary by location and protocol.

5,664 public trials 308 recruiting studies
Refine in advanced search Browse all conditions

Retroviridae Infections trial results

Completed

BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women

NCT00074425

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 3535 Market Street CRS Philadelphia, Pennsylvania, United States
  • University of North Carolina Lilongwe CRS Lilongwe, Central Region, Malawi
  • College of Med. JHU CRS Blantyre, Southern Region, Malawi
  • Chatsworth CRS Chatsworth, KwaZulu-Natal, South Africa
View Trial Details
Completed

A Safety and Immune Response Study of 2 Experimental HIV Vaccines

NCT02404311

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • CAPRISA eThekwini CRS Durban, KwaZulu-Natal, South Africa
  • Isipingo CRS Durban, KwaZulu-Natal, South Africa
  • Emavundleni Desmond Tutu HIV Centre CRS Cape Town, Western Cape, South Africa
  • Aurum Institute for Health Research Klerksdorp, South Africa
View Trial Details
Completed

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

NCT00074581

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Fenway Community Health Ctr. CRS Boston, Massachusetts, United States
  • Gaborone CRS Gaborone, Botswana
  • Hospital Geral de Nova Iguaçu CRS (HGNI CRS) Nova Iguaçu, Rio de Janeiro, Brazil
  • Hospital Nossa Senhora da Conceicao CRS Port Alegre, Rio Grande do Sul, Brazil
View all 17 locations
View Trial Details
Completed

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

NCT00006604

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB Pediatric Infectious Diseases CRS Birmingham, Alabama, United States
  • Usc La Nichd Crs Alhambra, California, United States
  • University of California, UC San Diego CRS La Jolla, California, United States
  • Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States
View all 36 locations
View Trial Details
Completed

Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB

NCT01751568

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations
  • Soweto IMPAACT CRS Johannesburg, Gauteng, South Africa
  • Wits RHI Shandukani Research Centre CRS Johannesburg, Gauteng, South Africa
  • Desmond Tutu TB Centre - Stellenbosch University (DTTC-SU) CRS Cape Town, Western Cape, South Africa
  • Famcru Crs Cape Town, Western Cape, South Africa
View Trial Details
Completed

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

NCT00109590

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Bhumibol Adulyadej Hosp. CRS Saimai, Bangkok, Thailand
  • Siriraj Hospital Mahidol University CRS Bangkok, Bangkoknoi, Thailand
  • Prapokklao Hosp. CRS Chanthaburi, Thailand
  • Chiang Mai University Pediatrics-Obstetrics CRS Chiang Mai, Thailand
View Trial Details
Completed

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

NCT01505114

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Bridge HIV CRS San Francisco, California, United States
  • George Washington Univ. CRS Washington D.C., District of Columbia, United States
  • Johns Hopkins University CRS Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Completed

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

NCT00766597

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UCSD Mother-Child-Adolescent Program CRS San Diego, California, United States
  • Children's National Med. Ctr. Washington DC NICHD CRS Washington D.C., District of Columbia, United States
  • Howard Univ. Washington DC NICHD CRS Washington D.C., District of Columbia, United States
  • Chicago Children's CRS Chicago, Illinois, United States
View Trial Details
Completed

Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

NCT02411539

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UCSD Antiviral Research Center CRS San Diego, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Johns Hopkins University CRS Baltimore, Maryland, United States
View all 13 locations
View Trial Details

Related conditions